Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more

Stroke

Volumn 27, Issue 8, 1996, Pages 1310-1315

  Basun, H ^a,b   Corder, E H ^a,b,c   Guo, Z ^a,b   Lannfelt, L ^a   Corder, L S ^c   Manton, K G ^c   Winblad, B ^a,b   Viitanen, M ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

^c DUKE UNIVERSITY   (United States)

Author keywords

aged; amyloid; apolipoproteins; cerebral hemorrhage; dementia

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; AGING; ARTICLE; BRAIN HEMORRHAGE; DEMENTIA; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; SURVIVAL RATE;

EID: 0029845764     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.8.1310     Document Type: Article

References (38)

1. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-12.
2. Hixson JE, for the Pathological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Apolipoprotein E polymorphism affects atherosclerosis in young males. Arterioscler Thromb. 1991; 11:1237-1244.
3. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem. 1993;39:2125-2129.
4. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, Bingham A, Amouyel P, Schaffer P, Ruidavets JB, Cambien F, Fruchart JC, Ducimetiere P. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: the ECTIM study. Arterioscler Thromb. 1994;14:1412-1419.
5. Van Bockxmeer FM, Mamotte CD. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet. 1992;340:879-880.
6. Kuusi T, Nieminen MS, Ehnholm C, Yki-Jarvinen H, Valle M, Nikkila EA, Taskinen MR. Apolipoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis. 1989;9: 237-241.
7. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, Neaton JD. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 1993;71:160-165.
8. Tiret L, de Knijff P, Menzel HJ, Ehnholm C, Nicaud V, Havekes LM, for the European Atherosclerosis Research (EARS) Study Group. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. Arterioscler Thromb. 1994;14:1617-1624.
9. Menzel HJ, Kiladetzky RG, Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis. 1983;3: 310-315.
10. Utermann G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet. 1984;65:237-241.
11. Stuyt PMJ, Brennikmeiger BJ, Demacker PNM, Hendriks JCM, van Elteren P, Stalenhoef AFH, van Laar A. Apolipoprotein phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease. Scand J Clin Lab Invest. 1991;51:425-435.
12. Marshall HW, Morrison LC, Wu LL, Anderson JL, Corneli PS, Stauffer BS, Allen A, Karagounis LA, Ward RH. Apolipoprotein polymorphisms fail to define risk of coronary artery disease: results of a prospective, angiographically controlled study. Circulation. 1994;89: 567-577.
13. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol. 1995;15:1280-1286.
14. Pedro-Botet J, Senti M, Nogués X, Rubies-Prat J, Roquer J, D'Olhaberriague L, Olivé J. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke. 1992;23: 1556-1562.
15. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke. 1993;24:661-664.
16. Saunders AM, Roses AD. Apolipoprotein E allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. Stroke. 1993;24:1416. Letter.
17. Couderc R, Mahieux F, Bailleul S. Apolipoprotein E allele frequency in ischemic cerebrovascular disease and Alzheimer's disease. Stroke. 1994;24:1416-1417.
18. Coria F, Rubio I, Nuñez E, Sempere AP, Santa Engracia N, Bayón C, Cuadrado N. Apolipoprotein E variants in ischemic stroke. Stroke. 1995;26:2375-2376. Letter.
19. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type ε4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:1977-1981.
20. Corder EH, Saunders AM, Strittmatter WJ, Schmechel D, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance M. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
21. Kuusisto J, Koivisto K, Kervinen K, Mykkänen L, Helkala E-L, Vanhanen M, Hänninen T, Pyörälä K, Kesäniemi YA, Riekkinen P, Laakso M. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ. 1994;309: 636-638.
22. Feskens EJM, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D. Apolipoprotein ε4 allele and cognitive decline in elderly men. BMJ. 1994;309:1202-1206.
23. Frisoni G, Geroldi C, Blanchetti A, Trabucchi M, Govoni S, Francheschini G, Calebresi L. Apolipoprotein ε4 allele frequency in vascular dementia and Alzheimer's disease. Stroke. 1994;25:1703. Letter.
24. Mahieux F, Couderc R, Bailleul S, Moulignier A. Apolipoprotein ε4 allele frequency in vascular dementia and Alzheimer's disease. Stroke. 1994;25:1703-1704. Letter response.
25. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Islaq T, Hyman BT. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol. 1995;38:254-259.
26. Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD. ApoE genotype and survival from intracerebral hemorrhage. Lancet. 1995;346:575. Letter.
27. Kalaria RN, Premkumar DRD. Apolipoprotein E genotype and cerebral amyloid angiopathy. Lancet. 1995;346:1424. Letter.
28. Jordan BD, Kanik AB, Horwich MS, Sweeney D, Relkin NR, Petito CK, Gandy S. Apolipoprotein E ε4 and fatal cerebral amyloid angiopathy associated with dementia pugilistica. Ann Neurol. 1995;28: 698-699. Letter.
29. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafström M, Holmén K, Ericsson K, Bäckman L, Ahlbom A, Winblad B. Prevalence of Alzheimer's disease in an elderly urban population: relationship with age, sex, and education. Neurology. 1991;41:1886-1892.
30. Fratiglioni L, Viitanen M, Bäckman L, Sandman P-O, Winblad B. Occurrence of dementia in advanced age: the study design of the Kungsholmen project. Neuroepidemiology. 1992;1:29-36.
31. World Health Organization. Manual of the International Classification of Diseases, Injuries and Causes of Death, 8th Revision. Geneva, Switzerland: World Health Organization; 1977:vol 1.
32. Corder EH, Lannfelt L, Viitanen M, Corder LS, Manton KG, Winblad B, Basun H. Apolipoprotein E genotype determines survival in the oldest old age >85 years who have good cognition. Arch Neurol. 1996;53:418-422.
33. SAS Technical Report P-179, Additional SAS/STAT Procedures, version 6.03. The Lifetest Procedure. Cary, NC: SAS Institute; 1988:49-89,519-640.
34. Kleinbaum DG, Kupper LL, Morgenstern H. Measures of potential impact and summary of the measures. In: Epidemiologic Research: Principles and Quantitative Methods. London, UK: Lifetime Learning Publications; 1982:161.
35. Winblad B, Corder E, Fratiglioni L, Basun H, Lannfelt L, Viitanen M. The prevalence of clinical dementia varies with apolipoprotein E. Neurobiol Aging. 1996; June. In press.
36. Lannfelt L, Lilius L, Nastase M, Viitanen M, Fratiglioni L, Eggertsen G, Berglund L, Angelin B, Linder J, Winblad B, Basun H. Lack of association between apolipoprotein E allele ε4 and sporadic Alzheimer's disease. Neurosci Lett. 1994;169:175-178.
37. Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stern Y, Sano M, Remien RH, Williams JB, Mohr JP, Hauser WA. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 1992;42:1185-1193.
38. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med. 1995;333:1242-1247.